Noveris Health Sciences is trading at CA$0.04 (-22.22%) amid a sharp decline in biotech and broader markets, consistent with sector-wide risk-off pressure.
- No company-specific announcement for November 5 surfaced in the search; available company-news listings point to earlier releases.
- Trading volume was not available, so activity level cannot be assessed.